7 years ago

Clinithink Secures Growth Equity Investment from TT Capital Partners and MSD Global Health Innovation Fund

  • Clinithink, a UK-based healthcare technology company, has secured a growth-equity investment from TT Capital Partners and the MSD Global Health Innovation Fund

  • The investment will be used to expand Clinithink's global presence and broaden its service offering

  • Clinithink uses AI to analyze clinical data, helping healthcare providers with patient care, rare disease identification, and clinical trial support

  • The company also assists biopharma and CROs with drug development and real-world data analysis.

      • ProblemHealthcare

      "Healthcare and life sciences organizations struggle to gain insights from clinical data, making it difficult to improve patient care, accelerate drug development, and optimize clinical trials."

      Solution

      "Clinithink's CLiX platform uses natural language processing (NLP) and artificial intelligence (AI) to analyze and interpret clinical data, extracting valuable insights that can be used to improve patient care, accelerate drug development, and optimize clinical trials."

      Covered on